Neogenomics Inc
Health Care
Neogenomics Inc (NEO) Stock News
The latest NEO headlines and market coverage — 3 recent stories, updated throughout the day.
- GlobeNewswire Inc.·
NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout
NeOnc Technologies announced Q2 2026 financial results with increased R&D spending of $2.6M (up from $0.7M YoY) to support clinical development. The company completed topline analysis of its Phase 2a NEO100 study in recurrent IDH1-mutant high-grade glioma with results to be presented August 12, 2026. NeOnc secured UAE IND approvals for both NEO100 and NEO212 programs and appointed Nasim Shomali to its Board. The company reported a net loss of $14.2M for Q2 2026 with $2.0M in cash and an undrawn $10M credit line.
- GlobeNewswire Inc.·
TPC Group to Be Acquired by ENEOS Holdings
ENEOS Holdings has agreed to acquire TPC Group, North America's largest independent C4 hydrocarbon processor, in a deal expected to strengthen ENEOS's position in the petrochemical C4 value chain and expand its U.S. operations. The acquisition includes TPC Group's Houston petrochemical operations and terminal facilities in Port Neches and Lake Charles. Regulatory approvals are expected by October 2026, with no planned changes to day-to-day operations prior to closing.
- GlobeNewswire Inc.·
Jimmy Oakes & ENEOS Debuted Ferrari-Powered Porsche 911!
Automotive content creator Jimmy Oakes debuted his 'Porrari' project at Formula DRIFT Connecticut, featuring a Ferrari-built Maserati F136 V8 engine swapped into a 1978 Porsche 911 SC. The ambitious build involved comprehensive restoration, custom fabrication, and performance upgrades, with ENEOS Motor Oil serving as the official lubricant partner.